Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged biotech · clear
Written by Mark E. Davis and Kerry S. Taylor, Ph.D. The PTAB issued two final written decisions upholding The University of Pennsylvania’s claims to methods of treating high cholesterol based, in part, on commercial success and the meaning of a…
Written by Sabrina Wang and Adam Powell The Federal Circuit held that a rat study in a provisional application and a conversion method in an uncited reference did not support the claimed human dosage form in Los Angeles Biomed. Research Inst. v. Eli Lilly…
Written by Scott Siera, Ph.D. and Michael L. Fuller Obtaining issued patents in the biotechnology space can be a challenge. Here is a list of ten patent strategies we recommend for biotechnology innovators to increase their odds of obtaining valuable…
Written by Kerry S. Taylor, Ph.D. and Nathanael Luman, Ph.D. The PTAB issued a Final Written Decision upholding Pozen’s ulcer reducing Vimovo® claims based on unexpected results in Coalition For Affordable Drugs VII LLC v. Pozen Inc.,…
Written by Caleb A. Bates, Ph.D. and Agnes Juang, Ph.D. On January 12, 2017, the U.S. Court of Appeals for the Federal Circuit issued an opinion affirming the judgement that Eli Lilly’s U.S. Patent No. 7,772,209 (“the ’209 Patent”)…
Written by Daniel K. Yarbrough, Ph.D. and Nathanael R. Luman, Ph.D. The PTAB denied institution of an IPR based on patent owner’s challenge to the prior art status of a PCT publication that was asserted by the petitioner as pre-AIA 35 U.S.C. §…
Written by Daniel A. Kamkar and Eric Furman, Ph.D. After the United Kingdom voted to leave the European Union, dubbed “Brexit” by the press, many have called into question whether the UK would ratify the Unitary Patent System. The Unitary…
Written by Scott Siera, Ph.D. and Agnes Juang, Ph.D. Patent applications containing nucleic acid or protein sequences are required to include an electronic sequence listing using a required format and standard symbols. The United States Patent and…
Unitary patents in Europe The European unitary patent and Unitary Patent Court (UPC) are slated to go into effect in early 2017. These monumental changes will have a significant impact on the ways patent rights are obtained and enforced in Europe.…
On July 14, 2016, the U.S. Patent and Trademark Office issued new subject matter eligibility guidance for life science claims following a ruling by the Federal Circuit in Rapid Litigation Management v. CellzDirect , No. 15-1570 (Fed. Cir. July 5, 2016),…
.jpg)
BRUSSELS (Reuters) - Belgian biotech firm Ablynx said on Friday that it had regained the rights for its TNF-Alpha targeting nanobodies from Pfizer, which form the basis of a rheumatoid arthritis drug currently undergoing clinical trials. Pfizer said it…
The Computer History Museum in Mountain View, CA was abuzz with coffee-fueled conversation the weekend of Oct. 21-22nd as a very diverse bunch - scientists, biotechnology lawyers, software designers, students, hardware developers, bioinformaticists,…
